Company intelligence / Profile preview

Translational Drug Development

Scottsdale, Arizona, United Statestd2inc.com ↗

Ownership: Private
Employees: ~75
Development stage: Other

Overview

TD2 has supported hundreds of first-in-human and early-phase oncology clinical trials, contributing to the approval of major cancer medicines. The company specializes in accelerating the development process for innovative therapies by integrating preclinical research, regulatory support, advanced flow cytometry, site networks, and comprehensive clinical trial management. They have been involved with more than 600 biotech/pharma companies. Pipeline breadth/pipeline details are not publicly disclosed as TD2 operates as a CRO supporting client pipelines rather than developing its own proprietary drugs.

Therapeutic areas: OncologyHematology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Not specifically listed; works with hundreds of biotech/pharma clients globally

Beyond the preview

Go deeper on Translational Drug Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translational Drug Development.

Explore the full profile